Search results
Analysts reveal Eli Lilly stock price targets after earnings
TheStreet via Yahoo Finance· 1 hour agoThe people at Eli Lilly (LLY) say they're working as fast as they can. The drugmaker, which reported...
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 10 hours agoEli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and ...
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
Motley Fool via Yahoo Finance· 55 minutes agoWhat also helped was the company's just-released first-quarter results, which boasted an earnings...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion By Reuters
Investing.com· 3 days agoLilly said it expects significant production increases in the second half of the year for its...
Novo Nordisk expects 27% sales surge this year but faces price pressure amid Eli Lilly competition
Fortune· 15 hours agoFruergaard Jorgensen said Thursday. Ramping up production is a key element of Novo’s strategy as it battles Eli Lilly & Co. for supremacy in the weight-loss ...
Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss
FierceBiotech· 10 hours agoThe approved GLP-1 medicines, Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, are known to cause...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 days agoEli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave ...
Amgen scraps experimental weight loss pill, moves forward with injection
NBC Philadelphia· 3 hours agoAmgen is scrapping an experimental weight loss pill but moving forward with an injection. Amgen is...
How Lilly is using its Mounjaro millions to position as biotechs’ ‘partner of choice’
FierceBiotech· 1 day agoEli Lilly’s explosion into the weight loss space is proving fruitful for shareholders, but it’s also...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
NBC Bay Area· 3 days agoEli Lilly reported first-quarter adjusted profit that topped Wall Street's expectations. The company also hiked its full-year guidance ...